Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 50.18% |
| Q2 2025 | 245.05% |
| Q1 2025 | -284.04% |
| Q4 2024 | 113.02% |
| Q3 2024 | -57.48% |
| Q2 2024 | 42.53% |
| Q1 2024 | -44.75% |
| Q4 2023 | -100.31% |
| Q3 2023 | 69.25% |
| Q2 2023 | -20.35% |
| Q1 2023 | 12.48% |
| Q4 2022 | 19.22% |
| Q3 2022 | 0.72% |
| Q2 2022 | 34.94% |
| Q1 2022 | 39.77% |
| Q4 2021 | -98.17% |
| Q3 2021 | 5.54% |
| Q2 2021 | -54.04% |
| Q1 2021 | 13.46% |
| Q4 2020 | -40.74% |
| Q3 2020 | 38.10% |
| Q2 2020 | 21.41% |
| Q1 2020 | 13.86% |
| Q4 2019 | -9.04% |
| Q3 2019 | 11.68% |
| Q2 2019 | -33.90% |
| Q1 2019 | -25.22% |
| Q4 2018 | -35.94% |
| Q3 2018 | -20.93% |
| Q2 2018 | -5.35% |
| Q1 2018 | -27.38% |
| Q4 2017 | -21.62% |
| Q3 2017 | -45.64% |
| Q2 2017 | -11.83% |
| Q1 2017 | 0.00% |